The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion.

PubWeight™: 2.99‹?› | Rank: Top 1%

🔗 View Article (PMC 1895717)

Published in Blood on November 17, 2005

Authors

Leonie M Kamminga1, Leonid V Bystrykh, Aletta de Boer, Sita Houwer, José Douma, Ellen Weersing, Bert Dontje, Gerald de Haan

Author Affiliations

1: Department of Cell Biology, Section Stem Cell Biology, University Medical Center Groningen, University of Groningen, The Netherlands.

Articles citing this

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev (2006) 14.36

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet (2010) 7.96

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev (2007) 6.77

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev (2007) 6.71

Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell (2010) 4.18

Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells (2008) 3.81

Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res (2008) 3.45

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc Natl Acad Sci U S A (2012) 3.22

Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol (2013) 3.07

Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev (2009) 3.02

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood (2009) 2.71

p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell (2010) 2.65

Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev (2009) 2.40

EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proc Natl Acad Sci U S A (2009) 2.25

Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep (2013) 2.19

Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell (2014) 2.18

Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell (2008) 2.08

Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc Natl Acad Sci U S A (2010) 1.97

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer (2010) 1.87

Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness. Nature (2013) 1.61

Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY) (2011) 1.58

Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. Cell Stem Cell (2013) 1.56

Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus. Proc Natl Acad Sci U S A (2009) 1.54

Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity. PLoS Biol (2008) 1.53

Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proc Natl Acad Sci U S A (2012) 1.52

Chromatin regulatory mechanisms in pluripotency. Annu Rev Cell Dev Biol (2010) 1.51

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Breast Cancer Res (2008) 1.42

EZH2 in normal and malignant hematopoiesis. Leukemia (2013) 1.28

The roles of EZH2 in cell lineage commitment. Am J Transl Res (2011) 1.24

Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells. Cancer Biol Ther (2009) 1.16

Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation. Nat Cell Biol (2013) 1.16

EZH2 depletion blocks the proliferation of colon cancer cells. PLoS One (2011) 1.15

Mechanisms of hematopoietic stem cell aging. Exp Gerontol (2009) 1.11

Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet (2014) 1.09

Recent progress toward epigenetic therapies: the example of mixed lineage leukemia. Blood (2013) 1.08

Large scale gene expression profiles of regenerating inner ear sensory epithelia. PLoS One (2007) 1.08

Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression. Oncotarget (2015) 1.05

Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells. Blood (2008) 1.05

EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence. Epigenetics Chromatin (2009) 1.05

Polycomb group genes: keeping stem cell activity in balance. PLoS Biol (2008) 1.05

Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence. Blood (2010) 1.04

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer. PLoS One (2013) 1.03

Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy. Haematologica (2011) 0.97

Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes. PLoS One (2012) 0.96

MicroRNA 146 (Mir146) modulates spermatogonial differentiation by retinoic acid in mice. Biol Reprod (2013) 0.96

Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells. Exp Hematol (2007) 0.95

Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype. J Ovarian Res (2008) 0.95

Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease. Cell Stem Cell (2015) 0.94

The chromodomain helicase Chd4 is required for Polycomb-mediated inhibition of astroglial differentiation. EMBO J (2013) 0.94

The epigenetic landscape of acute myeloid leukemia. Adv Hematol (2014) 0.94

The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis. J Leukoc Biol (2013) 0.92

Bmi1 confers resistance to oxidative stress on hematopoietic stem cells. PLoS One (2012) 0.91

Fak depletion in both hematopoietic and nonhematopoietic niche cells leads to hematopoietic stem cell expansion. Exp Hematol (2011) 0.90

The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation. Stem Cells Dev (2014) 0.89

Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential. Blood (2009) 0.88

Epigenetic control of adult stem cell function. Nat Rev Mol Cell Biol (2016) 0.88

Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease. Biol Blood Marrow Transplant (2010) 0.88

The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease. Blood (2013) 0.88

Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci Rep (2015) 0.86

Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects. Crit Rev Oncog (2011) 0.86

Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis. J Clin Invest (2015) 0.84

The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells. Blood (2014) 0.84

Relationships between hematopoiesis and hepatogenesis in the midtrimester fetal liver characterized by dynamic transcriptomic and proteomic profiles. PLoS One (2009) 0.83

The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes. Subcell Biochem (2014) 0.83

Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein. Leukemia (2011) 0.83

An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat Med (2016) 0.83

Epigenetic dysregulation in cancer. Am J Pathol (2009) 0.82

Modelling mammalian cellular quiescence. Interface Focus (2014) 0.82

Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells. PLoS One (2012) 0.81

EZH2 in normal hematopoiesis and hematological malignancies. Oncotarget (2016) 0.81

When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development (2016) 0.80

The role of chromatin modifiers in normal and malignant hematopoiesis. Blood (2013) 0.80

Posttranslational regulation of self-renewal capacity: insights from proteome and phosphoproteome analyses of stem cell leukemia. Blood (2012) 0.80

Cdc42 and aging of hematopoietic stem cells. Curr Opin Hematol (2013) 0.79

Regulation of T Cell Differentiation and Function by EZH2. Front Immunol (2016) 0.78

PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells. Sci Rep (2015) 0.78

H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer. Adv Cancer Res (2016) 0.78

Epigenetics of hematopoiesis and hematological malignancies. Genes Dev (2016) 0.77

EZH2 is overexpressed in laryngeal squamous cell carcinoma and enhances the stem-like properties of AMC-HN-8 cells. Oncol Lett (2016) 0.77

The epigenetic regulator CXXC finger protein 1 is essential for murine hematopoiesis. PLoS One (2014) 0.77

Evidence that hematopoietic stem cell function is preserved during aging in long-lived S6K1 mutant mice. Oncotarget (2016) 0.77

Trithorax and polycomb cooperation in MLL fusion acute leukemia. Haematologica (2013) 0.76

Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers. Transfusion (2014) 0.76

Genomic Analysis of Invasive Human Bone Marrow Derived Mesenchymal Stem Cells. J Bone Marrow Res (2013) 0.76

Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis. J Exp Med (2016) 0.75

Epigenetic perturbations in aging stem cells. Mamm Genome (2016) 0.75

The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9. Leukemia (2016) 0.75

Depletion of polycomb repressive complex 2 core component EED impairs fetal hematopoiesis. Cell Death Dis (2017) 0.75

As"SIRT"ing the role of an epigenetic modifier in hematopoietic stem cell homeostasis. Stem Cell Investig (2016) 0.75

Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells. Oncotarget (2016) 0.75

Normal formation of a vertebrate body plan and loss of tissue maintenance in the absence of ezh2. Sci Rep (2016) 0.75

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

The language of covalent histone modifications. Nature (2000) 44.92

Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol (1963) 29.15

Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (2002) 24.31

THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61

The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30

Purification and characterization of mouse hematopoietic stem cells. Science (1988) 15.99

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 14.35

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A (2003) 13.68

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A (2004) 9.42

The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev (2004) 7.89

Histone methylation in transcriptional control. Curr Opin Genet Dev (2002) 7.21

The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol (2001) 7.20

Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'. Nat Genet (2005) 6.91

The aging of hematopoietic stem cells. Nat Med (1996) 6.67

Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A (2005) 6.32

Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet (1999) 5.58

The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol (1995) 4.77

Related chromosome binding sites for zeste, suppressors of zeste and Polycomb group proteins in Drosophila and their dependence on Enhancer of zeste function. EMBO J (1993) 4.26

Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev (1995) 3.81

Genes controlling essential cell-cycle functions in Drosophila melanogaster. Genes Dev (1989) 3.50

Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med (1991) 3.48

Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes. Mol Cell Biol (1998) 3.30

Polycomb complexes and silencing mechanisms. Curr Opin Cell Biol (2004) 3.25

Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell (2005) 3.01

Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta (2002) 2.96

Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp Med (1982) 2.77

Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood (2002) 2.66

Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood (1997) 2.59

Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood (2001) 2.54

Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med (2004) 2.31

The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol (2001) 2.21

The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature (2004) 2.19

The role of stem cells in aging. Exp Hematol (2003) 2.13

Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood (1991) 2.02

Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev (1999) 1.95

Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene (2004) 1.94

HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells (2002) 1.94

Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol (2000) 1.69

Genetic regulation of primitive hematopoietic stem cell senescence. Exp Hematol (2000) 1.66

Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells. J Exp Med (2002) 1.62

Stage-specific expression of polycomb group genes in human bone marrow cells. Blood (1998) 1.62

Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene. J Exp Med (1997) 1.50

Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood (1989) 1.45

Chromatin complexes regulating gene expression in Drosophila. Curr Opin Genet Dev (1995) 1.44

Impaired hematopoietic stem cell functioning after serial transplantation and during normal aging. Stem Cells (2005) 1.35

A panel of monoclonal antibodies against human polycomb group proteins. Hybrid Hybridomics (2002) 1.33

The heterochromatin loss model of aging. Exp Gerontol (1997) 1.27

Epigenome changes in active and inactive polycomb-group-controlled regions. EMBO Rep (2004) 1.25

Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny. J Exp Med (1995) 1.20

Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. Exp Hematol (2004) 1.14

A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood (2002) 1.13

Proliferative involvement of ENX-1, a putative human polycomb group gene, in haematopoietic cells. Br J Haematol (2000) 1.06

Quantitative assessment of the stem cell self-renewal capacity. Ann N Y Acad Sci (2001) 0.96

Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras. Exp Hematol (1992) 0.95

Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy. Exp Hematol (1997) 0.89

Autonomous behavior of hematopoietic stem cells. Exp Hematol (2000) 0.87

Articles by these authors

The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37

Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'. Nat Genet (2005) 6.91

The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet (2003) 3.96

Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One (2008) 2.70

Genetical genomics: spotlight on QTL hotspots. PLoS Genet (2008) 2.63

The ageing haematopoietic stem cell compartment. Nat Rev Immunol (2013) 2.15

Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med (2011) 1.95

Expression quantitative trait loci are highly sensitive to cellular differentiation state. PLoS Genet (2009) 1.92

A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning. Stem Cells (2006) 1.84

Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood (2010) 1.81

In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev Cell (2003) 1.53

Asymmetry in skeletal distribution of mouse hematopoietic stem cell clones and their equilibration by mobilizing cytokines. J Exp Med (2014) 1.52

Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration. Exp Hematol (2010) 1.44

Growth factor treatment prior to low-dose total body irradiation increases donor cell engraftment after bone marrow transplantation in mice. Blood (2002) 1.38

Impaired hematopoietic stem cell functioning after serial transplantation and during normal aging. Stem Cells (2005) 1.35

Counting stem cells: methodological constraints. Nat Methods (2012) 1.35

Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool. Stem Cells (2008) 1.26

Hematopoietic stem cell expansion: challenges and opportunities. Ann N Y Acad Sci (2012) 1.25

A statistical multiprobe model for analyzing cis and trans genes in genetical genomics experiments with short-oligonucleotide arrays. Genetics (2005) 1.25

Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. Blood (2009) 1.24

Heterogeneity of young and aged murine hematopoietic stem cells revealed by quantitative clonal analysis using cellular barcoding. Blood (2013) 1.23

The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse. Biochem Biophys Res Commun (2005) 1.16

Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation. Nat Cell Biol (2013) 1.16

A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood (2002) 1.13

Cellular memory and hematopoietic stem cell aging. Stem Cells (2006) 1.10

Hematopoietic stem cell aging and self-renewal. Cell Tissue Res (2007) 1.10

Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1. Blood (2007) 1.08

Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells. Blood (2011) 1.07

Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? Hum Mol Genet (2006) 1.07

BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood (2010) 1.06

Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone. Haematologica (2012) 1.05

Fibroblast growth factors as regulators of stem cell self-renewal and aging. Mech Ageing Dev (2006) 1.01

Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells. Exp Hematol (2006) 1.00

Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization. Blood (2004) 1.00

Aging of hematopoietic stem cells: Intrinsic changes or micro-environmental effects? Curr Opin Immunol (2011) 0.99

Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. Stem Cells (2006) 0.99

Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia. J Biol Chem (2007) 0.98

In vitro assays for cobblestone area-forming cells, LTC-IC, and CFU-C. Methods Mol Biol (2008) 0.97

Stem cell assays: something old, something new, something borrowed. Stem Cells (2004) 0.96

Undifferentiated embryonic cell transcription factor 1 regulates ESC chromatin organization and gene expression. Stem Cells (2010) 0.95

Cytokine treatment improves parenchymal and vascular damage of salivary glands after irradiation. Clin Cancer Res (2008) 0.94

Bone marrow transplantation in mice as a tool for studying the role of hematopoietic cells in metabolic and cardiovascular diseases. Atherosclerosis (2010) 0.94

Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization. Antivir Ther (2004) 0.91

Levenshtein error-correcting barcodes for multiplexed DNA sequencing. BMC Bioinformatics (2013) 0.91

Combining transcriptional profiling and genetic linkage analysis to uncover gene networks operating in hematopoietic stem cells and their progeny. Immunogenetics (2008) 0.90

Enhancing the detection of barcoded reads in high throughput DNA sequencing data by controlling the false discovery rate. BMC Bioinformatics (2014) 0.87

Chemotherapy prior to autologous bone marrow transplantation impairs long-term engraftment in mice. Exp Hematol (2003) 0.84

Polycomb group proteins in hematopoietic stem cell aging and malignancies. Int J Hematol (2011) 0.83

Cerebellar heterokaryon formation increases with age and after irradiation. Stem Cell Res (2008) 0.83

Administration of low-dose cytarabine results in immediate S-phase arrest and subsequent activation of cell cycling in murine stem cells. Exp Hematol (2005) 0.82

Inferring combinatorial association logic networks in multimodal genome-wide screens. Bioinformatics (2010) 0.82

Hematopoietic stem cell quiescence: yet another role for p53. Cell Stem Cell (2009) 0.81

The combination of valproic acid and lithium delays hematopoietic stem/progenitor cell differentiation. Blood (2012) 0.81

Latexin is a newly discovered regulator of hematopoietic stem cells. Nat Genet (2007) 0.80

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7. Vaccine (2003) 0.79

Identification of quantitative trait loci regulating haematopoietic parameters in B6AKRF2 mice. Br J Haematol (2006) 0.78

A verification protocol for the probe sequences of Affymetrix genome arrays reveals high probe accuracy for studies in mouse, human and rat. BMC Bioinformatics (2007) 0.77

Shared Ageing Research Models (ShARM): a new facility to support ageing research. Biogerontology (2013) 0.77

Noncanonical Wnt comes of age in hematopoietic stem cells. Cell Stem Cell (2013) 0.76

Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function. Exp Hematol (2012) 0.76

Stem Cells and Aging: What's Next? Cell Stem Cell (2015) 0.75

The balance among immune suppression, stem cell ablation, competition, and engraftment. Blood (2004) 0.75

A novel growth factor encoded by an old gene. Haematologica (2005) 0.75

Barcoded vector libraries and retroviral or lentiviral barcoding of hematopoietic stem cells. Methods Mol Biol (2014) 0.75